September 15, 2025
How we use embeddings of clinical trial features to visualize and analyze the competitive biotech landscape.
Competitive Intel from What Biotech Does, Not What It Says
Biotech intelligence platform and research services for investors. Aggregated data from trials, filings, patents, and markets—organized to surface operational signals traditional analysis misses.
Clinical Trial Intelligence Platform
Track biotech pipelines, trial changes, and market movements in one place. Company-first organization, automatic change detection, and your research notes connected to live data from trials, filings, and markets.
Explore the Platform →
Recent Analysis
View allAugust 3, 2025
A technical walkthrough of how I used LLMs strategically to improve name harmonization for clinical trial sponsors while minimizing non-determinism.
June 30, 2025
Learn how to parse SEC Form D filings into a private capital database for biotech and venture research.
Biotech intelligence built for analysts and agile teams
RxDataLab provides a data platform and specialized intelligence services for biotech investors. We aggregate public data from clinical trial registries, regulatory filings, patent databases, and financial markets into company-centric views that surface operational signals. This combines systematic data infrastructure with domain expertise in neuroscience to assess what companies are actually doing, what’s likely next, and what investors should watch.
Ready to Talk?
Whether you're evaluating an investment opportunity, conducting due diligence, preparing for fundraising, or tracking competitive intelligence, We can provide the data and technical depth you need.
Get in Touch
Or email directly at
info@rxdatalab.com